Reg IV Is a Direct Target of Intestinal Transcriptional Factor CDX2 in Gastric Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Naito, Yutaka ^a   Oue, Naohide ^a   Hinoi, Takao ^a   Sakamoto, Naoya ^a   Sentani, Kazuhiro ^a   Ohdan, Hideki ^a   Yanagihara, Kazuyoshi ^b   Sasaki, Hiroki ^b   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; REGENERATING ISLET DERIVED FAMILY MEMBER 4 PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CELL STRAIN HT29; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; HISTONE METHYLATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGENERATING ISLET DERIVED FAMILY MEMBER 4 GENE; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HOMEODOMAIN PROTEINS; HUMANS; LECTINS, C-TYPE; LUCIFERASES; PLASMIDS; PROTEIN BINDING; RECEPTORS, ESTROGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84868313420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047545     Document Type: Article

References (46)

1. Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, et al. (2011) Molecular pathology of gastric cancer: research and practice. Pathol Res Pract 207: 608-12.
2. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, et al. (2004) Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-405.
3. Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, et al. (2006) Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25: 2546-57.
4. Hartupee JC, Zhang H, Bonaldo MF, Soares MB, Dieckgraefe BK, (2001) Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 1518: 287-93.
5. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, et al. (2006) Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 130: 137-49.
6. Legoffic A, Calvo E, Cano C, Folch-Puy E, Barthet M, et al. (2009) The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target. PLoS One 4: e7495.
7. Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, et al. (2012) Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-b. J Pathol, in press.
8. Mitani Y, Oue N, Matsumura S, Yoshida K, Noguchi T, et al. (2007) Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 26: 4383-93.
9. Tatematsu M, Tsukamoto T, Inada K, (2003) Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94: 135-41.
10. Motoshita J, Oue N, Nakayama H, Kuraoka K, Aung PP, et al. (2005) DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci 96: 474-9.
11. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, et al. (2005) Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 207: 185-98.
12. Takehara A, Eguchi H, Ohigashi H, Ishikawa O, Kasugai T, et al. (2006) Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci 97: 1191-7.
13. Nakata K, Nagai E, Ohuchida K, Aishima S, Hayashi A, et al. (2009) REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms. Mod Pathol 22: 460-8.
14. Oue N, Kuniyasu H, Noguchi T, Sentani K, Ito M, et al. (2007) Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 72: 371-80.
15. Ohara S, Oue N, Matsubara A, Mita K, Hasegawa Y, et al. (2008) Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer. Cancer Sci 99: 1570-7.
16. Sasahira T, Oue N, Kirita T, Luo Y, Bhawal UK, et al. (2008) Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland. Histopathology 53: 667-75.
17. Hayashi T, Matsubara A, Ohara S, Mita K, Hasegawa Y, et al. (2009) Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker. Oncol Rep 21: 95-100.
18. Tamura H, Ohtsuka M, Washiro M, Kimura F, Shimizu H, et al. (2009) Reg IV expression and clinicopathologic features of gallbladder carcinoma. Hum Pathol 40: 1686-92.
19. Sentani K, Oue N, Noguchi T, Sakamoto N, Matsusaki K, et al. (2010) Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin. Pathol Int 60: 291-7.
20. Heiskala K, Arola J, Heiskala M, Andersson LC, (2010) Expression of Reg IV and Hath1 in neuroendocrine neoplasms. Histol Histopathol 25: 63-72.
21. Wang F, Xu L, Guo C, Ke A, Hu G, et al. (2011) Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PLoS One 6: e18434.
22. Nanakin A, Fukui H, Fujii S, Sekikawa A, Kanda N, et al. (2007) Expression of the REG IV gene in ulcerative colitis. Lab Invest 87: 304-14.
23. Silberg DG, Swain GP, Suh ER, Traber PG, (2000) Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119: 961-71.
24. Hinoi T, Lucas PC, Kuick R, Kuick R, Hanash S, et al. (2002) CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123: 1565-77.
25. Almeida R, Silva E, Santos-Silva F, Silberg DG, Wang J, et al. (2003) Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 199: 36-40.
26. Margalit Y, Yarus S, Shapira E, Gruenbaum Y, Fainsod A, (1993) Isolation and characterization of target sequences of the chicken CdxA homeobox gene. Nucleic Acids Res 21: 4915-22.
27. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-7.
28. Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
29. Mossman D, Scott RJ, (2011) Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. PLoS One 6: e23127.
30. Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, et al. (2001) Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 159: 2239-48.
31. Hinoi T, Gesina G, Akyol A, Kuick R, Hanash S, et al. (2005) CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium. Gastroenterology 128: 946-61.
32. Takakura Y, Hinoi T, Oue N, Sasada T, Kawaguchi Y, et al. (2010) CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium. Cancer Res 70: 6767-78.
33. Anami K, Oue N, Noguchi T, Sakamoto N, Sentani K, et al. (2010) Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype. J Pathol 221: 275-84.
34. Pastan I, Gottesman MM, (1991) Multidrug resistance. Annu Rev Med 42: 277-86.
35. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, et al. (2003) Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil. J Cancer Res Clin Oncol 129: 683-90.
36. Motoshita J, Nakayama H, Taniyama K, Matsusaki K, Yasui W, (2006) Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype. Pathol Int 56: 200-5.
37. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, et al. (1998) High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 58: 14-19.
38. Ochiai A, Yasui W, Tahara E, (1985) Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 76: 1064-71.
39. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K, (1991) Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51: 381-6.
40. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, et al. (2004) Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 95: 575-82.
41. Hoji H, (1977) Establishiment of cultured cell lines of human stomach cancer - origin and their morphological characteristics. Niigata Igakukai Zasshi 91: 737-752.
42. Motoyama T, Hoji H, Watanabe H, (1986) Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. Jpn. 36: 65-83.
43. Sekiguchi M, Sakakibara K, Fuji G, (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn. J. Exp. Med. 48: 61-68.
44. Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, et al. (1993) Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 53: 36-41.
45. Gibson UE, Heid CA, Williams PM, (1996) A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001.
46. Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, et al. (2004) Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64: 523-9.